Search

Displaying results 7621 - 7630 of 10000 in total
  1. Drug

    Elarofiban anhydrous

    go.drugbank.com/drugs/DB21212
    Experimental

    The usage of the INN stem '-fiban' in the name indicates that Elarofiban anhydrous is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). … Elarofiban anhydrous is a small molecule drug.

  2. Drug

    Lifibrate

    go.drugbank.com/drugs/DB21399
    Experimental

    The usage of the INN stem '-fibrate' in the name indicates that Lifibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist. … Lifibrate is a small molecule drug.

  3. Drug

    RO7284755

    go.drugbank.com/drugs/DB17527
    Investigational

    RO7284755 is under investigation in clinical trial NCT04303858 (A Study to Evaluate Safety and Anti-tumor Activity of RO7284755 Alone or in Combination With Atezolizumab in Participants With Advanced And … RO7284755 is an investigational cancer drug: it is a PD-1-targeted IL-2 variant antibody fusion protein.

  4. Drug

    GW-559090

    go.drugbank.com/drugs/DB06508
    Experimental

  5. Drug

    Edaglitazone

    go.drugbank.com/drugs/DB06519
    Investigational

  6. Drug

    Tramiprosate

    go.drugbank.com/drugs/DB06527
    Investigational

  7. Drug

    Dextofisopam

    go.drugbank.com/drugs/DB06582
    Investigational

  8. Drug

    Omiganan

    go.drugbank.com/drugs/DB06610
    Investigational

    Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections.

  9. Drug

    Ditazole

    go.drugbank.com/drugs/DB08994
    ApprovedWithdrawn

    Additionally, ditazole is a platelet aggregation inhibitor marketed in Spain and Portugal with trade name Ageroplas. … Ditazole is a non-steroidal anti-inflammatory drug (NSAID). Ditazole's analgesic and antipyretic effects are similar to phenylbutazone.

  10. Drug

    Vafidemstat

    go.drugbank.com/drugs/DB16446
    Investigational

    Vafidemstat is under investigation in clinical trial NCT03867253 (Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease).